To compare efficacy and safety of two , once-daily basal insulin formulations [ insulin lispro protamine suspension ( ILPS ) vs. insulin glargine ( glargine ) ] added to oral antihyperglycaemic medications ( OAMs ) and exenatide BID in suboptimally controlled type 2 diabetes ( T2D ) patients .